Pioglitazone for type 2 diabetes mellitus
22 results
1 - 22
Pioglitazone for type 2 diabetes mellitus
Pioglitazone for type 2 diabetes mellitus - Pioglitazone for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk for the development of type 2 diabetes mellitus
Controversial evidence on value of pioglitazone (Actos) for type 2 diabetes- Comprehensive treatment and follow-up of type 2 diabetes
- Oral antidiabetic drugs and GLP-1 analogues
- Glucagon-like peptide analogues for type 2 diabetes mellitus: Cochrane systematic review
- Sulphonylurea monotherapy for patients with type 2 diabetes mellitus: Cochrane systematic review
- The use of glitazones (thiazolidinediones) in heart failure
- Metformin for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus
- Insulin monotherapy compared with the addition of oral glucose‐lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control
- Glucagon-like peptide analogues (GLP-1 analogues) for type 2 diabetes
- Insulin‐sensitising drugs (metformin, rosiglitazone, pioglitazone, D‐chiro‐inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility